280 related articles for article (PubMed ID: 33316045)
1. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review.
Nadeem U; Raafey M; Kim G; Treger J; Pytel P; N Husain A; Schulte JJ
Am J Clin Pathol; 2021 May; 155(6):793-801. PubMed ID: 33316045
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
[TBL] [Abstract][Full Text] [Related]
3. American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity.
Desmarais J; Rosenbaum JT; Costenbader KH; Ginzler EM; Fett N; Goodman S; O'Dell J; Pineau CA; Schmajuk G; Werth VP; Link MS; Kovacs R
Arthritis Rheumatol; 2021 Dec; 73(12):2151-2160. PubMed ID: 34697918
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
7. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
[TBL] [Abstract][Full Text] [Related]
8. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
[TBL] [Abstract][Full Text] [Related]
9. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
Sarayani A; Cicali B; Henriksen CH; Brown JD
Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.
Shah RR
J Clin Pharm Ther; 2021 Feb; 46(1):17-27. PubMed ID: 32981089
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
Kumar J; Jain S; Meena J; Yadav A
J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
[TBL] [Abstract][Full Text] [Related]
13. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C; Fernando SD; Rajapakse S
Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
Kashour Z; Riaz M; Garbati MA; AlDosary O; Tlayjeh H; Gerberi D; Murad MH; Sohail MR; Kashour T; Tleyjeh IM
J Antimicrob Chemother; 2021 Jan; 76(1):30-42. PubMed ID: 33031488
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.
Nicolò M; Ferro Desideri L; Bassetti M; Traverso CE
Int Ophthalmol; 2021 Feb; 41(2):719-725. PubMed ID: 32946004
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center.
Choi MY; Weber B; Stevens E; Guan H; Ellrodt J; Oakes E; Di Carli M; Tedrow U; Sauer W; Costenbader KH
Rheumatol Int; 2022 Oct; 42(10):1767-1774. PubMed ID: 35430712
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine-induced cardiomyopathy: a reversible cause of heart failure.
Yogasundaram H; Hung W; Paterson ID; Sergi C; Oudit GY
ESC Heart Fail; 2018 Jun; 5(3):372-375. PubMed ID: 29460476
[TBL] [Abstract][Full Text] [Related]
18. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
Altulea D; Maassen S; Baranov MV; van den Bogaart G
J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
[TBL] [Abstract][Full Text] [Related]
19. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
Pereira BB
J Toxicol Environ Health B Crit Rev; 2020 May; 23(4):177-181. PubMed ID: 32281481
[TBL] [Abstract][Full Text] [Related]
20. An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy.
Celotto S; Veronese N; Barbagallo M; Ometto F; Smith L; Pardhan S; Barnett Y; Ilie PC; Soysal P; Lagolio E; Kurotschka PK; Tonelli R; Demurtas J
Int J Infect Dis; 2021 Feb; 103():599-606. PubMed ID: 33316389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]